AMY DAVID: Open Payments
NPI 1255848719 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 12 payments from 6 companies in 2025. Trend: 2023 $266 · 2024 $80 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 2 | $114 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| AYTU BioPharma, Inc. | 2 | $34 |
| CSL Behring | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Xhance, FASENRA, Karbinal, Hizentra, TEZSPIRE, NUCALA.
Industry payments across LA — which companies pay providers there.
